- Home
- VRDN vs XHR Comparison
VRDN vs XHR Comparison
Compare VRDN & XHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- XHR
- Stock Information
- Founded
- VRDN 2006
- XHR 2007
- Country
- VRDN United States
- XHR United States
- Employees
- VRDN N/A
- XHR N/A
- Industry
- VRDN Medical Specialities
- XHR Real Estate Investment Trusts
- Sector
- VRDN Health Care
- XHR Real Estate
- Exchange
- VRDN Nasdaq
- XHR Nasdaq
- Market Cap
- VRDN 1.5B
- XHR 1.3B
- IPO Year
- VRDN N/A
- XHR N/A
- Fundamental
- Price
- VRDN $18.72
- XHR $14.42
- Analyst Decision
- VRDN Strong Buy
- XHR Buy
- Analyst Count
- VRDN 11
- XHR 6
- Target Price
- VRDN $38.80
- XHR $13.83
- AVG Volume (30 Days)
- VRDN 894.1K
- XHR 938.6K
- Earning Date
- VRDN 08-06-2025
- XHR 10-31-2025
- Dividend Yield
- VRDN N/A
- XHR 3.89%
- EPS Growth
- VRDN N/A
- XHR 193.03
- EPS
- VRDN N/A
- XHR 0.62
- Revenue
- VRDN $305,000.00
- XHR $1,075,161,000.00
- Revenue This Year
- VRDN N/A
- XHR $3.94
- Revenue Next Year
- VRDN $35,092.81
- XHR $2.87
- P/E Ratio
- VRDN N/A
- XHR $23.26
- Revenue Growth
- VRDN 5.90
- XHR 4.81
- 52 Week Low
- VRDN $9.90
- XHR $8.55
- 52 Week High
- VRDN $27.20
- XHR $16.50
- Technical
- Relative Strength Index (RSI)
- VRDN 55.80
- XHR 65.61
- Support Level
- VRDN $18.12
- XHR $13.78
- Resistance Level
- VRDN $20.05
- XHR $14.34
- Average True Range (ATR)
- VRDN 1.02
- XHR 0.33
- MACD
- VRDN -0.02
- XHR 0.07
- Stochastic Oscillator
- VRDN 55.81
- XHR 77.84
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About XHR Xenia Hotels & Resorts Inc.
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The firm's customer groups include transient business, group business, and contract business.